Mas S
Mas S
Unitat Farmacologia Dpt. Fonaments Clínics Facultat de Medicina Universitat de Barcelona
Dirección de correo verificada de ub.edu
Título
Citado por
Citado por
Año
Effects of milk supplementation with conjugated linoleic acid (isomers cis-9, trans-11 and trans-10, cis-12) on body composition and metabolic syndrome …
N Laso, E Brugué, J Vidal, E Ros, JA Arnaiz, X Carné, S Vidal, S Mas, ...
British journal of nutrition 98 (4), 860-867, 2007
1022007
Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells
P Gassó, S Mas, O Molina, M Bernardo, A Lafuente, E Parellada
Progress in Neuro-Psychopharmacology and Biological Psychiatry 36 (1), 71-77, 2012
642012
Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough: the role of ACE, ABO, and BDKRB2 genes
S Mas, P Gassò, S Alvarez, J Ortiz, JM Sotoca, A Francino, X Carne, ...
Pharmacogenetics and genomics 21 (9), 531-538, 2011
552011
Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics
A Lafuente, M Bernardo, S Mas, A Crescenti, M Aparici, P Gassó, ...
Schizophrenia research 90 (1-3), 115-122, 2007
542007
Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia
B García-Bueno, P Gassó, KS MacDowell, LF Callado, S Mas, ...
Journal of psychiatry & neuroscience: JPN 41 (3), E46, 2016
502016
Common genetic background in anorexia nervosa and obsessive compulsive disorder: preliminary results from an association study
S Mas, MT Plana, J Castro-Fornieles, P Gassó, A Lafuente, E Moreno, ...
Journal of psychiatric research 47 (6), 747-754, 2013
502013
Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with …
A Lafuente, M Bernardo, S Mas, A Crescenti, M Aparici, P Gasso, ...
Psychiatry research 161 (2), 131-141, 2008
492008
A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms
P Gassó, S Mas, M Bernardo, S Álvarez, E Parellada, A Lafuente
The pharmacogenomics journal 9 (6), 404-410, 2009
472009
Intuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypes
S Mas, P Gassò, S Alvarez, E Parellada, M Bernardo, A Lafuente
The pharmacogenomics journal 12 (3), 255-259, 2012
442012
Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patients
P Gassó, S Mas, O Molina, A Lafuente, M Bernardo, E Parellada
Journal of psychiatric research 48 (1), 94-101, 2014
422014
CYP2D6*3, *4, *5 AND *6 POLYMORPHISMS AND ANTIPSYCHOTIC‐INDUCED EXTRAPYRAMIDAL SIDE‐EFFECTS IN PATIENTS RECEIVING …
A Crescenti, S Mas, P Gassó, E Parellada, M Bernardo, A Lafuente
Clinical and Experimental Pharmacology and Physiology 35 (7), 807-811, 2008
422008
Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with schizophrenia in a Spanish population
A Crescenti, P Gassó, S Mas, R Abellana, R Deulofeu, E Parellada, ...
Psychiatry research 165 (1-2), 175-180, 2009
382009
Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients
P Gassó, N Rodríguez, S Mas, M Pagerols, A Blázquez, MT Plana, ...
The pharmacogenomics journal 14 (5), 457-462, 2014
372014
DNA cards: determinants of DNA yield and quality in collecting genetic samples for pharmacogenetic studies
S Mas, A Crescenti, P Gassó, JM Vidal‐Taboada, A Lafuente
Basic & clinical pharmacology & toxicology 101 (2), 132-137, 2007
372007
Modelling gene-environment interaction in first episodes of psychosis
M Bernardo, M Bioque, B Cabrera, A Lobo, A González-Pinto, L Pina, ...
Schizophrenia research 189, 181-189, 2017
332017
Pharmacogenetic predictor of extrapyramidal symptoms induced by antipsychotics: multilocus interaction in the mTOR pathway
S Mas, P Gassó, MA Ritter, C Malagelada, M Bernardo, A Lafuente
European Neuropsychopharmacology 25 (1), 51-59, 2015
332015
-141C Ins/Del polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in a Spanish population
A Lafuente, M Bernardo, S Mas, A Crescenti, M Aparici, P Gassó, J Goti, ...
Psychiatric genetics 18 (3), 122-127, 2008
332008
Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia
J Costas, N Carrera, P Alonso, X Gurriarán, C Segalàs, E Real, ...
Translational psychiatry 6 (3), e768-e768, 2016
302016
Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia
J Costas, N Carrera, P Alonso, X Gurriarán, C Segalàs, E Real, ...
Translational psychiatry 6 (3), e768-e768, 2016
302016
Association between genetic variants related to glutamatergic, dopaminergic and neurodevelopment pathways and white matter microstructure in child and adolescent patients with …
P Gassó, AE Ortiz, S Mas, A Morer, A Calvo, N Bargalló, A Lafuente, ...
Journal of affective disorders 186, 284-292, 2015
302015
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20